Late Diagnosis and Delay in Treatment of Cervical Cancer in the Brazilian Amazon: Evidence from a Reference Hospital
DOI:
https://doi.org/10.36557/2674-8169.2026v8n6p1331-1343Keywords:
Cervical Neoplasms, Neoplasm StagingAbstract
Introduction: Cervical cancer (CCU) is the second most common neoplasm in the North and Northeast regions of Brazil and is responsible for 7.5% of all cancer deaths in the female population. Objective: To identify the stage at diagnosis and the interval between diagnosis and the start of treatment of cervical cancer in women treated at a reference hospital in the Brazilian Amazon. Methodology: Retrospective study, conducted with data from the Hospital Cancer Registry of a public hospital in Roraima, from 2018 to 2023. Sociodemographic variables, clinical staging, and the interval between diagnosis and treatment were analyzed using descriptive statistics. Results: 271 women were included, with a mean age of 46.1 years. A predominance of diagnoses in advanced stages was observed, with stages IIB (29.15%) and IIIB (28.78%) standing out, totaling 57.93% of cases. Early stages represented 19.19%. The average time between diagnosis and the start of treatment was 157 days, with a median of 142 days, exceeding the legal deadline of 60 days. Conclusion: A high frequency of late diagnosis and delays in starting treatment were evident, indicating weaknesses in screening and in the organization of the healthcare network. This reinforces the need to strengthen early detection efforts and ensure timely access to treatment, especially in more vulnerable regions.lth.
Downloads
References
Ministério da Saúde (BR). Instituto Nacional de Câncer (INCA). Coordenação de Prevenção e Vigilância. Dados e números sobre câncer do colo do útero. Relatório Anual 2023. [Internet]. Rio de Janeiro, Brasil [acesso 2026 mar 06]. Disponível em: https://www.gov.br/inca/pt-br/assuntos/cancer/numeros/estimativa/estado-capital/roraima
Nasioudis D, George EM, Tanyi JL. Controversies in the staging of patients with locally advanced cervical cancer. Diagnostics (Basel), Pensilvânia, Filadélfia, Estados Unidos. CA Câncer J Clin [Internet] 2023 [cidet 2026 March 08];13(10):1747. Available fron: https://doi.org/10.3390/diagnostics13101747
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. [Internet] 2024. [cidet 2026 March 03];74(3):229-63. Available fron: https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21834
Ministério da Saúde (BR). Instituto Nacional de Câncer (INCA). Coordenação de Prevenção e Vigilância. Dados e números sobre câncer do colo do útero. Relatório Anual. Rio de Janeiro, Brasil. [Internet]. 2023. [acesso 2026 mar 03]. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/dados_e_numeros_colo_22marco2023.pdf .
Instituto Nacional de Câncer (INCA). Coordenação de Prevenção e Vigilância. Divisão de Detecção Precoce e Apoio à Organização. Dados e números sobre câncer do colo do útero. Relatório Anual 2023. Rio de Janeiro, Brasil [Internet]. 2023 [acesso 09 Mar 26]. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/ document/dados_e_numeros_colo_22marco2023.pdf. Acesso em: 03 mar 2026.
Silva JNS, et al. Sobrevida de mulheres com câncer do colo do útero no Norte do Brasil. Revista de Pesquisa Cuidado é Fundamental Online. Vol. 18 e-14340. [Internet]. 2026 [acesso 2026 abr 30]. Disponível em: https://doaj.org/article/5fb513d67104445e9d025ead95d49a17
Favaro CRP. Perfil epidemiológico de mulheres com câncer de colo do útero atendidas em hospital do interior paulista. [Mestrado em Enfermagem]. São Paulo (Brasil) da Universidade de São Paulo -USP; 2017. [acesso 2026 fev]. Disponível em: https://www.teses.usp.br/teses/disponiveis/22/22133/tde-04052017-162425/publico/CAROLINERIBEIROPEREIRAFAVARO.pdf
CONSELHO NACIONAL DE SAÚDE (Brasil). Resolução nº 466, de 12 de dezembro de 2012. Diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Brasília, DF, Brasil, [Internet]. 2012. [acesso 2026 jun 15]. Disponível https://bvsms.saude.gov.br/bvs/saudelegis/cns/2013/res0466_12_12_2012.html
World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: WHO; [Internet]. 2020. [cidet 2026 April 30]; Disponível em: https://iris.who.int/handle/10665/336583
Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. N Engl J Med. [Internet]. 2019.[ cidet 2026 April 29]. 381(26):2455–2465. Disponível : https://doi.org/10.1056/NEJMra1814256
Sankaranarayanan R, et al. Efeito da triagem visual na incidência e mortalidade do câncer do colo do útero em Tamil Nadu, Índia: um estudo randomizado por cluster. Lanceta. [Internet]. 2007; [acesso 2026 fev 04]. 370(9585):398-406. Disponível em: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(07)61195-7/abstract
Corrêa CSL, et al. Cervical cancer screening in Brazil: challenges and opportunities. Front Med. [Internet]. 2022. [cidet 2026 April 28]. 9:945621. Disponível em: https://doi.org/10.3389/fmed.2022.945621
Paim J, Travassos C, Almeida C, Bahia L, Macinko J. The Brazilian health system: history, advances, and challenges. Lancet. [Internet]. 2019; [cidet 2026 April 28]. 377(9779):1778–1797. Disponível em: https://doi.org/10.1016/S0140-6736(11)60054-8
Mara HRC, Reis FJC, Andrade JR, et al. Estadiamento cirúrgico do câncer de colo de útero localmente avançado. Ver Bras Ginecol Obstet. [Internet]. 2005. [acesso 2026 fev 04]; Disponível em: https://www.scielo.br/j/rbgo/a/pF9ksg7NbBZVHvYKCxkFYXS/?format=html&lang=pt
Torres KL, et al. Cervical cancer screening in the Amazon region: challenges and perspectives. PLoS One. [Internet]. 2021. [cidet 2026 April 30] ;16(10).e 0258539. Disponível em: https://doi.org/10.1371/journal.pone.0258539
Medeiros GC, et al. Delay in breast and cervical cancer treatment in Brazil. Rev Saúde Pública. [Internet]. 2020. [cidet 2026 April 29] ;54:1–10. Disponível em: https://doi.org/10.11606/s1518-8787.2020054001888
BRASIL. Lei Federal nº 12.732, de 22 de novembro de 2012. Dispõe sobre o primeiro tratamento de paciente com neoplasia maligna comprovada e estabelece prazo para seu início. Planalto Gov.Brasília, Disponível em: https://www.planalto.gov.br/ccivil_03/_ato2011-2014/2012/lei/l12732.htm .
Hanna TP, King WD, Thibodeau S, et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ. [Internet]. 2020. [cidet 2026 April 29].371:m4087. Disponbível em: https://doi.org/10.1136/bmj.m4087
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 João Neto de Sousa da Silva, Patrícia Claro dos Santos Fuly, Bárbara Almeida Soares Dias, Valdecyr Herdy Alves, Pedro Eduardo Lima Siqueira

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are copyright holders under a CCBY 4.0 license.



